Prelude Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 2,494,934 | 4.53% |
Individual Insiders | 3,277,540 | 5.96% |
Institutions | 11,613,237 | 21.1% |
VC/PE Firms | 16,589,442 | 30.1% |
Hedge Funds | 21,060,017 | 38.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,293,897 | US$16.6m | 0% | 0.17% | |||
16,589,442 | US$15.9m | 0% | 0.24% | |||
3,766,120 | US$3.6m | -8.88% | 0.07% | |||
2,163,369 | US$2.1m | 0% | no data | |||
1,708,187 | US$1.6m | -33.5% | 0.12% | |||
1,379,182 | US$1.3m | 54.7% | no data | |||
1,068,916 | US$1.0m | 0% | no data | |||
1,021,770 | US$981.0k | 1.11% | no data | |||
921,621 | US$884.8k | 0% | 0.01% | |||
890,000 | US$854.5k | 0% | 0.05% | |||
551,776 | US$529.8k | 0% | no data | |||
549,530 | US$527.6k | 5.2% | no data | |||
500,098 | US$480.1k | 0% | no data | |||
391,716 | US$376.1k | 8.22% | no data | |||
359,137 | US$344.8k | 0% | no data | |||
321,966 | US$309.1k | 12.8% | no data | |||
312,048 | US$299.6k | 0% | no data | |||
286,046 | US$274.6k | 35.1% | no data | |||
196,900 | US$189.0k | -4.7% | no data | |||
180,685 | US$173.5k | 0% | no data | |||
176,100 | US$169.1k | 42.5% | no data | |||
174,979 | US$168.0k | 885% | no data | |||
160,652 | US$154.2k | 0% | no data | |||
160,524 | US$154.1k | 0% | no data | |||
133,249 | US$127.9k | 4.07% | no data |